Atossa Therapeutics

-$0.05 (-1.77%) Today
-$0.03 (-1.08%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATOS and other ETFs, options, and stocks.

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests.

CEO
Steven C. Quay
Employees
8
Headquarters
Seattle, Washington
Founded
2008

ATOS Key Statistics

Market Cap
352.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.70M
High Today
$2.81
Low Today
$2.69
Open Price
$2.79
Volume
3.41M
52 Week High
$9.80
52 Week Low
$0.81

ATOS Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure